452 BET inhibition markedly inhibits CTCL cell viability and is synergistically potentiated by BCL2 or HDAC inhibition
Autor: | Kim, S., Cyrenne, B., Lewis, J., Monico, P., Mirza, F., Carlson, K., Foss, F.M., Girardi, M. |
---|---|
Zdroj: | In Journal of Investigative Dermatology May 2018 138(5) Supplement:S77-S77 |
Databáze: | ScienceDirect |
Externí odkaz: |